Cardiac Biomarker in Pediatric Heart Disease

Okayama University74 enrolled

Overview

The purpose of this study is to investigate cardiac biomarker during perioperative management in pediatric cardiac surgery.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Congenital Heart Disease

Eligibility

Sex: ALLMax age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * children who receive surgery for congenital heart disease * require cardiopulmonary bypass for surgery * under 18 years old Exclusion Criteria: * simple congenital heart disease (atrial septal defect, ventricle septal defect, patent ductus arteriosus)

Locations (1)

Okayama University Hospital

Okayama, Okayama-ken, Japan

Outcomes

Primary Outcomes

serious adverse events

Time frame: one month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.